Revolutionary drug for schizophrenia wins US approval
Elie Dolgin • September 26, 2024
The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom relief with fewer side effects.
In response to cellular stress, proteins become ensnared in chemical traffic jams, creating a kind of widespread sluggishness scientists call “proteolethargy.”
USEFUL LINKS
CONTACT
elie@eliedolgin.com
Contact Us
Thank you for contacting us. We will get back to you as soon as possible.
Oops, there was an error sending your message. Please try again later.